Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Increases By 44.1%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 377,600 shares, an increase of 44.1% from the December 15th total of 262,000 shares. Approximately 11.0% of the company’s stock are sold short. Based on an average daily volume of 1,060,000 shares, the short-interest ratio is currently 0.4 days.

China SXT Pharmaceuticals Price Performance

SXTC traded up $0.02 during trading on Thursday, reaching $0.41. The stock had a trading volume of 85,490 shares, compared to its average volume of 813,889. The stock’s 50 day moving average is $0.42 and its two-hundred day moving average is $0.68. China SXT Pharmaceuticals has a one year low of $0.30 and a one year high of $3.37.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Read More

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.